Care Access Research, Orlando

Orlando, Florida 32825

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed